Skip to main content

Table 2 Correlation between TFRC expression and clinicopathological parameters in three tumors

From: LASS2 suppresses metastasis in multiple cancers by regulating the ferroptosis signalling pathway through interaction with TFRC

Characteristic

TFRC ID score

Thyroid cancer

 

Breast cancer

 

Hepatocellular carcinoma

0–4

6–12

P value

0–4

6–12

P value

0–4

6–12

P value

Sex

  

0.129

Age (years)

  

0.471

Sex

  

0.084

 Male

10

7

 

    < 51

9

9

 

    Male

20

11

 

 Female

14

3

 

    ≥ 51

5

7

 

    Female

7

0

 

Age (years)

  

0.334

Tumor size

  

0.236

Age (years)

  

1.00

 < 55

22

8

 

    ≤ 2 cm

2

3

 

    < 50

9

3

 

 ≥ 55

2

2

 

    > 2 cm

12

13

 

    ≥ 50

18

8

 

Tumor size

  

0.017*

TNM stage

  

0.015*

TNM stage

  

0.000*

 ≤ 2 cm

14

10

 

    I

0

2

 

    I

5

0

 

 > 2 cm

10

0

 

    II

6

13

 

    II

20

3

 

LNM

  

0.000*

    III

5

0

 

    III

1

8

 

 Negative

2

9

 

    IV

3

1

 

    IV

1

0

 

 Positive

22

1

 

Metastases

  

0.249

    
    

    Negative

3

1

     
    

    Positive

11

15

     
    

LNM

  

0.183

    
    

    Negative

11

9

     
    

    Positive

3

7

    Â